Confidential © 2024 Novocu © 2025 re GmbH Novocure GmbH 1 © 20254 Novocure GmbH GmbH 4 © 2025 Novocure GmbH 2 2025 key objectives, unlocking TTFields potential | DRIVING COMMERCIAL | ADVANCING | DELIVERING | | --- | --- | --- | | ADOPTION | CLINICAL PIPELINE | PRODUCT INNOVATION | | ✔ NSCLC drive global active | ✔ PANOVA-3 present and | V Launch MyNovocure | | patient growth and | publish data | patient app | | pursue reimbursement | • PANOVA-3 submit to FDA, | • New array utilized by | | ✔ NSCLC CE Mark | ...